Vistara— a highly reliable non-invasive fetal DNA screening test (without entering the abdominal cavity) that can provide important information about serious inherited disorders affecting the musculoskeletal, cardiovascular and nervous systems, involving 30 genes.
Vistara screens for selected single-gene conditions that may not be identified through routine chromosomal screening.
The combined frequency of the conditions listed here was estimated as approximately 1 in 600.
This estimate is higher than the frequency cited there for Down syndrome.
Conditions screened:
| SYNDROMES | |
| Condition | Gene |
| Alagille syndrome | JAG1 |
| CHARGE syndrome | CHD7 |
| Cornelia de Lange syndrome1 | NIPBL |
| Cornelia de Lange syndrome2 | SMC1A |
| Cornelia de Lange syndrome3 | SMC3 |
| Cornelia de Lange syndromee4 | RAD21 |
| Cornelia de Lange syndrome5 | HDAC8 |
| Early infantile epileptic encephalopathy,2 | CDKL5 |
| Intellectual disability | SYNGAP1 |
| Rett syndrome | MECP2 |
| Sotos syndrome 1 | NSD1 |
| Tuberous sclerosis 1 | TSC1 |
| Tuberous sclerosis 2 | TSC2 |
| CRANIOSYNOSTOSIS | |
| Condition | Gene |
| Antley–Bixler syndrome without genital anomalies | FGFR2 |
| Apert syndrome | |
| Crouzon syndrome | |
| Jackson–Weiss syndrome | |
| Pfeiffer syndrome1/2/3 | |
| SKELETAL DISORDERS | |
| Condition | Gene |
| Achondroplasia | FGFR3 |
| CATSHL syndrome | |
| Crouzon syndrome with acanthosis nigricans | |
| Hypochondroplasia | |
| Muenke syndrome | |
| Thanatophoric dysplasia, typeI | |
| Thanatophoric dysplasia, typeII | |
| Ehlers–Danlos syndrome, classical type | COL1A1 |
| Ehlers–Danlos syndrome, typeVIIA | |
| Osteogenesis imperfecta, typeI | |
| Osteogenesis imperfecta, typeII | |
| Osteogenesis imperfecta, type | |
| Osteogenesis imperfecta, type IV | |
| Ehlers–Danlos syndrome, cardiac valvular type | COL1A2 |
| Ehlers–Danlos syndrome, type VIIB | |
| Osteogenesis imperfecta, typeII | |
| Osteogenesis imperfecta, typeIII | |
| Osteogenesis imperfecta, typeIV | |
| AUTISM SPECTRUM DISORDERS | |
| Condition | Gene |
| Cardiofaciocutaneous syndrome1 | BRAF |
| Cardiofaciocutaneous syndrome3 | MAP2K1 |
| Cardiofaciocutaneous syndrome4 | MAP2K2 |
| Costello syndrome / Noonan syndrome | HRAS |
| Noonan syndrome 1 /LEOPARD syndrome | PTPN11 |
| Noonan syndrome 4 | SOS1 |
| Noonan syndrome 5 /LEOPARD
syndrome 2 |
RAF1 |
| Noonan syndrome 6 / tumors | NRAS |
| Noonan syndrome 8 | RIT1 |
| Noonan syndrome 9 | SOS2 |
| Noonan syndrome / tumors | KRAS |
| Noonan-like syndromes with hair loss | SHOC2 |
| Noonan-like syndromes without juvenile myelomonocytic leukemia | CBL |
Indications:
Test advantages:
Testing limitations:
Sample required: Venous blood from the mother and father.
Turnaround time: 21 working days.
Test price: For pricing information, please contact our consultant.
Attention! Blood for testing must be collected no earlier than nine weeks into an ongoing pregnancy.
Have a question?
Let us discuss it. Complete the form and our specialist will answer your questions.
We serve patients across Georgia!